Prostate-specific membrane antigen and uses thereof
AssigneeSloan-Kettering Institute for Cancer Research
InventorsRon S. Israeli, Warren D.W. Heston, William R. Fair, Ouathek Ouerfelli, John Pinto
Life of this patent
Estimating the term…
Loading patent…
AssigneeSloan-Kettering Institute for Cancer Research
InventorsRon S. Israeli, Warren D.W. Heston, William R. Fair, Ouathek Ouerfelli, John Pinto
Estimating the term…
This invention provides an isolated nucleic acid molecule encoding an alternatively spliced human prostate-specific membrane antigen. This invention provides an isolated nucleic acid comprising a promoter sequence normally associated with the transcription of a gene encoding a human prostate-specific membrane antigen. This invention provides an isolated polypeptide having the biological activity of an alternatively spliced prostate-specific membrane antigen. This invention provides a method of detecting a nucleic acid encoding an alternatively spliced human prostate-specific membrane antigen and a method of detecting a prostate tumor cell in a subject. Lastly, this invention provides a pharmaceutical composition comprising a compound in a therapeutically effective amount and a pharmaceutically acceptable carrier and a method of making prostate cells susceptible to a cytotoxic chemotherapeutic agent.
An isolated nucleic acid encoding an alternatively spliced human prostate-specific membrane antigen.
An isolated nucleic acid comprising a promoter sequence normally associated with the transcription of a gene encoding a human prostate-specific membrane antigen.
An isolated polypeptide having the biological activity of an alternatively spliced prostate-specific membrane antigen.
A method of detecting in a sample the presence of a nucleic acid encoding an alternatively spliced human prostate-specific membrane antigen which comprises:
A method of detecting a prostate tumor cell in a subject which comprises:
A compound comprising a conjugate of a cytotoxic agent and one or more amino acid residues, wherein each amino acid residue is glutamate or aspartate.
Dependencies are inferred from the claim text.